EUFEMED webinar 'Phase 1 Vaccine Studies in the Times of Covid-19…'

We invite you for this free EUFEMED webinar.
COVID has highlighted the importance of Phase 1 trials with vaccines. And yet, only a handful of sponsors, Phase 1 sites  and investigators have a thorough understanding of the science, methodology, ethics and logistics required to run suchtrials. This New Years EUFEMED webinar will provide you with cutting-edge insight into newest developments around such trials while also learning about the experience of others and providing an opportunity to discuss recommendations.

REGISTER HERE

Schedule of this EUFEMED webinar 'Phase 1 Vaccine Studies in the Times of Covid-19…'

On Thursday 28 January:
16:00 - 16:10 Welcome and introduction
16:10 - 16:40 An overview of current vaccine platforms and the development of a new vaccine against SARS-CoV-2 Johan Neyts, Rega Institute, KU Leuven, Belgium Q&A
16:40 - 17:10 The challenges of setting up a Phase 1 vaccine trial during the Corona pandemic: The sponsor’s point of view Johan Van Hoof, Janssen Pharmaceutica, Beerse, Belgium Q&A
17:10 - 17:30 The challenges of conducting a Phase 1 vaccine trial during the Corona pandemic: The investigator’s point of view Wouter Botermans, Center for Clinical Pharmacology, KU Leuven, Belgium Q&A
17:30 - 17:40 General Discussion
17:40 - 18:00 Closing remarks

Show full schedule

Share with others